Intravenous DMPS chelation therapy, as performed in this office, typically involves DMPS followed by glutathione, and then followed by vitamin C all administered intravenously, the total procedure taking approximately 1-2 hours. Glutathione and vitamin C improve effectiveness and reduce chances of adverse reactions. Vitamin C helps to additionally remove toxic metals. The frequency of intravenous administrations varies with individual patient circumstances, once weekly being average. DMPS is often used to target mercury toxicity. EDTA may be used to target lead. Both DMPS and EDTA remove various toxic metals but to different degrees.
Intravenous DMPS Provocative challenge test
After the intravenous procedure is completed urine is collected in a container over the range of 6 to 20 hours depending upon individual patient need. The toxic burden of toxic metals, including mercury, is indirectly measured in the urine The total volume of fluid is measured by recording the number on the gradation scale of the urine container corresponding to fluid level within. Urine from the container is placed into a small tube which is sealed and mailed to the laboratory along with a record of the total urine volume. The laboratory results are interpreted by the doctor once they arrive from the laboratory.
The combination of the DMPS infusion and the analysis of the toxic metal content in the urine is called the “provocative challenge test.” This test measures the excretion of metals in the urine provoked by the DMPS infusion. This test is performed periodically to gain clinically strategic information about the body burden of toxic metals, quantitatively and qualitatively.